Literature DB >> 25580597

Genomic discovery of potent chromatin insulators for human gene therapy.

Mingdong Liu1, Matthew T Maurano2, Hao Wang2, Heyuan Qi3, Chao-Zhong Song4, Patrick A Navas1, David W Emery4, John A Stamatoyannopoulos5, George Stamatoyannopoulos6.   

Abstract

Insertional mutagenesis and genotoxicity, which usually manifest as hematopoietic malignancy, represent major barriers to realizing the promise of gene therapy. Although insulator sequences that block transcriptional enhancers could mitigate or eliminate these risks, so far no human insulators with high functional potency have been identified. Here we describe a genomic approach for the identification of compact sequence elements that function as insulators. These elements are highly occupied by the insulator protein CTCF, are DNase I hypersensitive and represent only a small minority of the CTCF recognition sequences in the human genome. We show that the elements identified acted as potent enhancer blockers and substantially decreased the risk of tumor formation in a cancer-prone animal model. The elements are small, can be efficiently accommodated by viral vectors and have no detrimental effects on viral titers. The insulators we describe here are expected to increase the safety of gene therapy for genetic diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25580597     DOI: 10.1038/nbt.3062

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  50 in total

1.  The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.

Authors:  A C Bell; A G West; G Felsenfeld
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

Review 2.  The insulation of genes from external enhancers and silencing chromatin.

Authors:  Bonnie Burgess-Beusse; Catherine Farrell; Miklos Gaszner; Michael Litt; Vesco Mutskov; Felix Recillas-Targa; Melanie Simpson; Adam West; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

3.  Gene therapy for SCID-X1: focus on clinical data.

Authors:  Christopher Baum
Journal:  Mol Ther       Date:  2011-12       Impact factor: 11.454

4.  Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.

Authors:  Annette Deichmann; Salima Hacein-Bey-Abina; Manfred Schmidt; Alexandrine Garrigue; Martijn H Brugman; Jingqiong Hu; Hanno Glimm; Gabor Gyapay; Bernard Prum; Christopher C Fraser; Nicolas Fischer; Kerstin Schwarzwaelder; Maria-Luise Siegler; Dick de Ridder; Karin Pike-Overzet; Steven J Howe; Adrian J Thrasher; Gerard Wagemaker; Ulrich Abel; Frank J T Staal; Eric Delabesse; Jean-Luc Villeval; Bruce Aronow; Christophe Hue; Claudia Prinz; Manuela Wissler; Chuck Klanke; Jean Weissenbach; Ian Alexander; Alain Fischer; Christof von Kalle; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 5.  Insulators: exploiting transcriptional and epigenetic mechanisms.

Authors:  Miklos Gaszner; Gary Felsenfeld
Journal:  Nat Rev Genet       Date:  2006-08-15       Impact factor: 53.242

6.  Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator.

Authors:  Chang Long Li; Ding Xiong; George Stamatoyannopoulos; David W Emery
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

7.  Gene therapy fulfilling its promise.

Authors:  Donald B Kohn; Fabio Candotti
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

8.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

9.  Critical DNA binding interactions of the insulator protein CTCF: a small number of zinc fingers mediate strong binding, and a single finger-DNA interaction controls binding at imprinted loci.

Authors:  Mario Renda; Ilaria Baglivo; Bonnie Burgess-Beusse; Sabrina Esposito; Roberto Fattorusso; Gary Felsenfeld; Paolo V Pedone
Journal:  J Biol Chem       Date:  2007-09-07       Impact factor: 5.157

10.  Design and analysis of ChIP-seq experiments for DNA-binding proteins.

Authors:  Peter V Kharchenko; Michael Y Tolstorukov; Peter J Park
Journal:  Nat Biotechnol       Date:  2008-11-16       Impact factor: 54.908

View more
  42 in total

Review 1.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Gene therapy: insulating from genotoxicity.

Authors:  Darren J Burgess
Journal:  Nat Rev Genet       Date:  2015-01-28       Impact factor: 53.242

3.  Controlling gene activation by enhancers through a drug-inducible topological insulator.

Authors:  Taro Tsujimura; Osamu Takase; Masahiro Yoshikawa; Etsuko Sano; Matsuhiko Hayashi; Kazuto Hoshi; Tsuyoshi Takato; Atsushi Toyoda; Hideyuki Okano; Keiichi Hishikawa
Journal:  Elife       Date:  2020-05-05       Impact factor: 8.140

Review 4.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

Review 5.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

6.  Insulated Foamy Viral Vectors.

Authors:  Diana L Browning; Casey P Collins; Jonah D Hocum; David J Leap; Dustin T Rae; Grant D Trobridge
Journal:  Hum Gene Ther       Date:  2016-03-15       Impact factor: 5.695

7.  Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.

Authors:  Michael Aaron Goodman; Paritha Arumugam; Devin Marie Pillis; Anastacia Loberg; Mohammed Nasimuzzaman; Danielle Lynn; Johannes Christiaan Maria van der Loo; Phillip Joseph Dexheimer; Mehdi Keddache; Thomas Roy Bauer; Dennis Durand Hickstein; David William Russell; Punam Malik
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

Review 8.  Gene Therapy for β-Hemoglobinopathies.

Authors:  Marina Cavazzana; Chiara Antoniani; Annarita Miccio
Journal:  Mol Ther       Date:  2017-04-01       Impact factor: 11.454

Review 9.  Retroviral vector interactions with hematopoietic cells.

Authors:  Elizabeth M Everson; Grant D Trobridge
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

Review 10.  Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects.

Authors:  Jorge Mansilla-Soto; Isabelle Riviere; Farid Boulad; Michel Sadelain
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.